May 15 (Reuters)-
Delta-Fly Pharma, Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2025 Mar 31, 2024 Mar 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Operating loss 1.71 loss 1.40 loss 1.50
Recurring loss 1.72 loss 1.43 loss 1.51
Net loss 1.72 loss 1.43 loss 1.51
EPS loss 195.58 yen loss 198.78 yen loss 155.45 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Delta-Fly Pharma, Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T